Bladder Cancer - Results from #260

Loss of MTAP expression is strongly linked to homozygous 9p21 deletion, unfavorable tumor phenotype, and noninflamed microenvironment in urothelial bladder cancer. December 16, 2024

Survival after trimodal therapy in octogenarians with organ-confined urothelial bladder cancer. December 16, 2024

Real-World Treatment Patterns and Clinical Outcomes in Patients With Locally Advanced or Metastatic Urothelial Carcinoma by Eligibility for Maintenance Avelumab. December 13, 2024

Health-Related Quality of Life Across the Spectrum of Bladder Cancer: A Current Review. December 13, 2024

Urinary Diversion Versus Adverse In-Hospital Outcomes After Radical Cystectomy. December 12, 2024

The need for a second transurethral resection in high-risk non-muscle-invasive bladder cancer based on the Vesicle Imaging-Reporting and Data System. December 12, 2024

Sarcopenia may increase cisplatin toxicity in bladder cancer patients with borderline renal function. December 11, 2024

A Predictive Nomogram for Development of Lymph Node Metastasis in Muscle-Invasive Bladder Cancer Following Neoadjuvant Therapy. December 11, 2024

UGN-102 Showed Promising Long-Term Results in the Phase 3 ENVISION Trial, Potentially Paving the Way for First FDA-Approved Treatment for LG-IR-NMIBC December 10, 2024

Co-inhibition of PGF and VEGFA enhances the effectiveness of immunotherapy in bladder cancer. December 10, 2024

Safety and efficacy of the MP1000 surgical system in robot-assisted radical cystectomy: A prospective study. December 10, 2024

Virtual simulator for cystoscopy containing motion blur and bladder debris to aid the development of clinical tools. December 9, 2024

High-Risk Non-Muscle Invasive Bladder Cancer: outcomes of patients who cannot benefit from Standard of Care. December 9, 2024

IMFINZI® (durvalumab) Granted Priority Review in the US for Patients with Muscle-invasive Bladder Cancer December 6, 2024

The impact of positive surgical margins after cystectomy on oncological outcomes: a nationwide study. December 6, 2024

Protein profile in urinary extracellular vesicles is a marker of malignancy and correlates with muscle invasiveness in urinary bladder cancer. December 6, 2024

Performance of urinary markers in patients with suspicious cystoscopy during follow-up of recurrent non-muscle invasive bladder cancer: BTA stat®, NMP22® BladderChek®, UBC® Rapid Test, CancerCheck® UBC® rapid VISUAL, and uromonitor® in comparison to cytol December 5, 2024

Long-term quality of life in patients with bladder cancer following radical cystectomy. December 5, 2024

Intraoperative Tranexamic Acid in Radical Cystectomy: Impact on Bleeding, Thromboembolism, and Survival Outcomes. December 4, 2024

Assessing the influence of smoking on inflammatory markers in bacillus Calmette Guérin response among bladder cancer patients: a novel machine-learning approach. December 4, 2024

Page 14 of 535